BUHLMANN Diagnostic Corp – New Partner Channel Agreement with Roche Diagnostics.
- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
BUHLMANN News
Key Highlights BUHLMANN Diagnostics Corp is excited to share highlights from our participation at Digestive Disease Week (DDW) 2024, held May 18-21 in Washington, D.C. Here is a brief overview of our assays offerings and the innovative research we presented. DDW 2024 Assay Offerings At BUHLMANN, we offer the broadest range of fecal calprotectin (fCAL)
Continue Reading
In this LabSense News Q3 2024 we're covering KLAR Partners Acquires BÜHLMANN Laboratories AG, New Partnership-Worldwide Collaboration with Beckman Coulter Dx, Poster Corner- BÜHLMANN posters from IFCC WorldLab 2024, Recent & Upcoming Meetings- IFCC WorldLab, ADLM, AMLI.
Continue Reading
BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. BÜHLMANN fPELA® turbo is FDA 510(k) Exempt. For in vitro Diagnostic Use. CALEX® Cap Updates CALEX Cap 4.0- Improved Total Laboratory Automation (TLA), or Block Automation & Seamless Integration TLA Compatibility: CALEX®Cap 4.0 integrates smoothly with TLA, enhancing workflow efficiency on
Continue Reading
In this "Q2 2024 Edition" we introduced CALEX Cap Updates- Extended Stability, Training Video & CALEX Cap 4.0, Poster Corner- BUHLMANN posters from ECCO & AAAAI 2024 and Recent & Upcoming Meetings- DDW & 2024.
Continue Reading
AMLI 2024 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Visit www.buhlmannlabs.com or email info@buhlmannlabs.com for more information. AMLI 2024 37th AMLI Annual Meeting Aug 16-19,
Continue Reading
Book a Meeting ADLM 2024 Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap;
Continue Reading
Assay Offerings Assay Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap; FDA exempt BÜHLMANN fPELA® turbo (Pancreatic Elastase); Tests
Continue Reading
BÜHLMAN sCAL turbo assay is for Research Use Only. Not for use in diagnostic procedures in the US. BÜHLMANN sCAL® turbo Serum Calprotectin (sCAL, aka: myeloid-related protein 8/14 (MRP8/14), S100A8/A9, calprotectin) is a powerful biomarker to study the inflammatory status of a subject whether it is a classical autoimmune mediated Rheumatoid Arthritis (RA) or a rare
Continue Reading
Book a Meeting AACC 2023 Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including FDA cleared and Research Use Only (RUO) kits. These fCAL related tests include FDA 510(k) cleared BÜHLMANN fCAL® ELISA, BÜHLMANN fCAL® turbo & CALEX® Cap;
Continue Reading
